Liquid biomarkers for fibrotic NASH – progress in a complex field

Bibliographic Details
Main Authors:	Myneni, S. (Author), Schuppan, D. (Author), Surabattula, R. (Author)
Format:	Article
Language:	English
Published:	Elsevier B.V. 2022
Subjects:	assay biological marker Biomarkers blood analysis Companion biomarker disease exacerbation Editorial fibrogenesis fibrosis Fibrosis human Humans liver biopsy liver fibrosis NAFLD nonalcoholic fatty liver Non-alcoholic Fatty Liver Disease prediction proteomics screening test serum marker
Online Access:	View Fulltext in Publisher


LEADER	01313nam a2200469Ia 4500
001	10-1016-j-jhep-2021-11-005
008	220420s2022 CNT 000 0 und d
020			\|a 01688278 (ISSN)
245	1	0	\|a Liquid biomarkers for fibrotic NASH – progress in a complex field
260		0	\|b Elsevier B.V. \|c 2022
300			\|a 3
856			\|z View Fulltext in Publisher \|u https://doi.org/10.1016/j.jhep.2021.11.005
650	0	4	\|a assay
650	0	4	\|a biological marker
650	0	4	\|a biological marker
650	0	4	\|a Biomarkers
650	0	4	\|a blood analysis
650	0	4	\|a Companion biomarker
650	0	4	\|a disease exacerbation
650	0	4	\|a Editorial
650	0	4	\|a fibrogenesis
650	0	4	\|a fibrogenesis
650	0	4	\|a fibrosis
650	0	4	\|a Fibrosis
650	0	4	\|a human
650	0	4	\|a Humans
650	0	4	\|a liver biopsy
650	0	4	\|a liver biopsy
650	0	4	\|a liver fibrosis
650	0	4	\|a liver fibrosis
650	0	4	\|a NAFLD
650	0	4	\|a nonalcoholic fatty liver
650	0	4	\|a nonalcoholic fatty liver
650	0	4	\|a Non-alcoholic Fatty Liver Disease
650	0	4	\|a prediction
650	0	4	\|a proteomics
650	0	4	\|a screening test
650	0	4	\|a serum marker
700	1	0	\|a Myneni, S. \|e author
700	1	0	\|a Schuppan, D. \|e author
700	1	0	\|a Surabattula, R. \|e author
773			\|t Journal of Hepatology

Similar Items